Patient Leaflet Updated 17-May-2024 | AbbVie Ltd
Glecaprevir/Pibrentasvir 50 mg/20 mg coated granules in sachet
Glecaprevir/Pibrentasvir 50 mg/20 mg coated granules in sachet
1. What Glecaprevir/Pibrentasvir is and what it is used for
2. What you need to know before your child takes Glecaprevir/Pibrentasvir
3. How to take Glecaprevir/Pibrentasvir
4. Possible side effects
5. How to store Glecaprevir/Pibrentasvir
6. Contents of the pack and other information
7. Instructions for use
Glecaprevir/Pibrentasvir is an antiviral medicine used to treat children aged 3 years and older with long-term (‘chronic’) hepatitis C. This is an infectious disease that affects the liver, caused by the hepatitis C virus. Glecaprevir/Pibrentasvir contains the active substances glecaprevir and pibrentasvir.
Glecaprevir/Pibrentasvir works by stopping the hepatitis C virus from multiplying and infecting new cells. This allows the infection to be eliminated from the body.
Do not give Glecaprevir/Pibrentasvir to your child if any of the above apply. If you are not sure, talk to your child’s doctor or pharmacist before giving Glecaprevir/Pibrentasvir.
Talk to your child’s doctor if they have the following because the doctor may want to check your child more closely:
Your child’s doctor will test their blood before, during and after treatment with Glecaprevir/Pibrentasvir. This is so that the doctor can decide if:
Do not give this medicine to children under 3 years of age or weighing less than 12 kg. The use of Glecaprevir/Pibrentasvir in children under 3 years of age or weighing less than 12 kg has not yet been studied.
Tell your child’s doctor or pharmacist if they are taking, have recently taken or might take any other medicines.
Tell your child’s doctor or pharmacist before giving Glecaprevir/Pibrentasvir, if they are taking any of the medicines in the table below. The doctor may need to change the dose of these medicines.
Medicines you must tell your child’s doctor about before giving Glecaprevir/Pibrentasvir
Medicine Purpose of the medicine
ciclosporin, tacrolimus to suppress the immune system
darunavir, efavirenz, lopinavir, ritonavir for HIV infection
digoxin for heart problems
fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin to lower blood cholesterol
warfarin and other similar medicines* to prevent blood clots
*Your child’s doctor may need to increase the frequency of blood tests to check how well your child’s blood can clot.
If any of the above apply to your child (or you are not sure), talk to your child’s doctor or pharmacist before giving Glecaprevir/Pibrentasvir.
If you have been told by your doctor that your child has an intolerance to some sugars, contact your doctor before giving this medicine.
This medicine contains 4 mg propylene glycol in each sachet.
This medicine contains less than 1 mmol sodium (23 mg) per sachet, that is to say essentially ‘sodium free’.
Always give this medicine exactly as your child’s doctor or pharmacist has told you. Check with your child’s doctor or pharmacist if you are not sure. Glecaprevir/Pibrentasvir coated granules are intended for children aged 3 years to less than 12 years and weighing 12 kg to less than 45 kg. Glecaprevir/Pibrentasvir tablets are intended for adults, children 12 years and older, or children weighing 45 kg or more.
Your child’s doctor will tell you how long your child needs to take Glecaprevir/Pibrentasvir for.
The recommended dose for children 3 to less than 12 years old is based on their body weight as shown in the table below.
Weight of child (kg) Number of sachets once daily
From 12 to less than 20 kg 3 sachets
From 20 to less than 30 kg 4 sachets
From 30 to less than 45 kg 5 sachets
For children weighing 45 kg or more, talk to your child’s doctor about giving Glecaprevir/Pibrentasvir tablets.
If your child is sick (vomits) after taking Glecaprevir/Pibrentasvir it may affect the amount of Glecaprevir/Pibrentasvir in their blood. This may make Glecaprevir/Pibrentasvir work less well.
If they accidentally take more than the recommended dose, contact your child’s doctor or go to the nearest hospital straight away. Take the medicine pack with you so that you can show the doctor what your child has taken.
It is important not to miss a dose of this medicine.
If your child does miss a dose, work out how long it is since they should have last taken Glecaprevir/Pibrentasvir:
If you have any further questions on the use of this medicine, ask your child’s doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Not known: frequency cannot be estimated from the available data
If your child gets any side effects, talk to your child’s doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and sachet after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Glecaprevir/Pibrentasvir contains lactose, propylene glycol and sodium. See section 2.
Glecaprevir/Pibrentasvir coated granules are supplied in polyester/aluminium/polyethylene film sachets in cartons. Each carton contains 28 sachets. Each sachet contains pink and yellow granules.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
United Kingdom
This leaflet was last revised in 02/2024
To listen to or request a copy of this leaflet in Braille, large print or audio, please contact the local representative of the Marketing Authorisation Holder.
Please read all of section 7 before using Glecaprevir/Pibrentasvir granules in sachets.
Weight of child (kg) Number of sachets once daily
From 12 to less than 20 kg 3 sachets
From 20 to less than 30 kg 4 sachets
From 30 to less than 45 kg 5 sachets
Food Amount (approximate)
About 1-2 teaspoons (5-10 mL) of recommended food listed in step 2
For children weighing 45 kg or more, talk to your child’s doctor about giving Glecaprevir/Pibrentasvir tablets.
Do not give more than 5 sachets.
Suitable food should stick to the spoon. It must be soft, low in water content and can be swallowed without chewing.
Example of recommended foods:
Note: in addition to the food used to mix the granules, Glecaprevir/Pibrentasvir should also be taken at the same time or straight after a meal or snack. The food used to mix the granules does not replace the meal or snack to take with Glecaprevir/Pibrentasvir.
Do not use food if it drips off a spoon as the medicine may dissolve quickly, taste bitter, and become less effective. Do not use food that your child is allergic to.
Example of foods not to use:
For more information about suitable foods, contact your child’s doctor or pharmacist.
Place the following on a clean surface:
Be Careful: Granules are very small and can fall out easily.
Look inside each sachet to make sure there are no granules left inside.
Do not leave any granules behind as the medicine will not work as well if the full dose is not taken.
If not given within 5 minutes, the mixture may taste bitter.
If not given within 15 minutes, the medicine may be less effective. Throw away and start again.
If your child misses a dose, see Section 3 “How to take Glecaprevir/Pibrentasvir” for further information.
Check to make sure there are enough sachets for your child’s next dose of Glecaprevir/Pibrentasvir.
For replacement sachets or to refill your prescription contact your child’s doctor or pharmacist.
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
www.abbviemedinfo.com
+44 (0)1628 561 092
+44 (0)1628 561 092
www.abbvie.co.uk
0800 783 1699